|
Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19 |
|
|
|
Titel: |
Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19 |
Auteur: |
Mao, Long Shaabani, Namir Zhang, Xiaoying Jin, Can Xu, Wanhong Argent, Christopher Kushnareva, Yulia Powers, Colin Stegman, Karen Liu, Jia Xie, Hui Xu, Changxu Bao, Yimei Xu, Lijun Zhang, Yuren Yang, Haigang Qian, Shengdian Hu, Yong Shao, Jianping Zhang, Can Li, Tingting Li, Yi Liu, Na Lin, Zhenhao Wang, Shanbo Wang, Chao Shen, Wei Lin, Yuanlong Shu, Dan Zhu, Zhenhong Kotoi, Olivia Kerwin, Lisa Han, Qing Chumakova, Ludmila Teijaro, John Royal, Mike Brunswick, Mark Allen, Robert Ji, Henry Lu, Hongzhou Xu, Xiao |
Verschenen in: |
Med |
Paginering: |
Jaargang 5 () nr. 2 pagina's 169-171 |
Jaar: |
2024 |
Inhoud: |
|
Uitgever: |
The Author(s) |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|